If you are a Healthcare Professional and you would like to log in to access this content, please click "Login".
You are now leaving the Lilly Medical Web site
Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Strattera® (atomoxetine): Use With COVID-19 Vaccines
The use of vaccines against SARS-CoV-2 in patients treated with atomoxetine has not been studied.
of COVID-19 Vaccines to Patients Receiving Atomoxetine
acute respiratory syndrome coronavirus 2 is an emerging virus that
has caused the recent COVID-19 pandemic.1
Recently, vaccines have been developed against SARS-CoV-2 and
additional vaccines are expected to be available in the coming
Vaccination With Atomoxetine
use of a SARS-CoV-2 vaccine in patients treated with atomoxetine has
not been studied by Lilly.
regarding the use of any vaccination, including SARS-CoV-2 vaccines,
in patients treated with atomoxetine should be made at the discretion
of the prescribing physician using their best clinical judgment, and
must be made by the clinician after careful consideration of risk
factors of the patient as well as the risks and benefits of
vaccination. Consultation with an infectious disease expert may be
helpful in high-risk or emergency situations such as the current
Su Z, Wen J, McDonnell D, et al. Vaccines are not yet a silver
bullet: The imperative of continued communication about the
importance of COVID-19 safety measures. Brain Behav Immun Health.
= coronavirus disease 2019
= Eli Lilly and Company
= severe acute respiratory syndrome coronavirus 2
Date of Last Review:January 15, 2021
Are you satisfied with this content?
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at firstname.lastname@example.org